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Acute myeloid leukemia (AML) in first remission (CR1) with isolated NPM1 mutation
(iNPM1m) is considered a good prognosis genotype, although up to one-third
relapse. To evaluate the best transplant strategy, we retrospectively compared
autologous stem cell transplantation (auto-SCT), related (MSD), and fully matched
unrelated (MUD) allogeneic stem cell transplantation (allo-SCT). We identified 256
adult patients including 125 auto-SCT, 72 MSD, and 59 MUD. The 2-year leukemia-
free survival (LFS) was 62% in auto-SCT, 69% in MUD, and 81% in MSD (P = .02 for
MSD vs others). The 2-year overall survival (OS) was not different among auto-SCT,
MUD, and MSD, reaching 83% (P = .88). The 2-year non-relapse mortality (NRM)
was 2.5% in auto-SCT and 7.5% in allo-SCT (P = .04). The 2-year cumulative
incidence of relapse (RI) was higher after auto-SCT (30%) than after MUD (22%) and
MSD (12%, P = .01). In multivariate analysis, MSD versus auto-SCT but not MUD
versus auto-SCT was associated with lower RI (P < .01 and P = .13, respectively) and
better LFS (P = .01 and P = .31, respectively). Age correlated with higher NRM
(P < .01). Allo-SCT using MSD appears as a reasonable transplant option for young
patients with iNPM1m AML in CR1. Auto-SCT was followed by worse RI and LFS, but
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